Cases 1 - 10 of 17
Kent v. Turning Point Therapeutics, Inc. et al
as 1:2022cv00879
Plaintiff:
Michael Kent
Defendant:
Turning Point Therapeutics, Inc., Mark J. Alles, Barbara W. Bodem and others
Hopkins v. Turning Point Therapeutics, Inc. et al
as 1:2022cv05433
Plaintiff:
Matthew Hopkins
Defendant:
Turning Point Therapeutics, Inc., Athena M. Countouriotis, Mark Alles and others
Whitfield v. Turning Point Therapeutics, Inc. et al
as 1:2022cv05439
Plaintiff:
Matthew Whitfield
Defendant:
Turning Point Therapeutics, Inc., Athena M. Countouriotis, Mark Alles and others
Cause Of Action: 12 U.S.C. § 22 Securities Fraud
O'Dell v. Turning Point Therapeutics, Inc. et al
as 1:2022cv05352
Plaintiff:
Ryan O'Dell
Defendant:
Turning Point Therapeutics, Inc., Mark J. Alles, Barbara W. Bodem and others
Williams v. Five Prime Therapeutics, Inc. et al
as 1:2021cv00508
Plaintiff:
Charles Williams
Defendant:
Peder K. Jensen, Thomas Civik, Carol Schafer and others
Thomas v. Five Prime Therapeutics, Inc. et al
as 4:2021cv02477
Defendant:
Peder K. Jensen, Thomas Civik, Carol Schafer and others
Plaintiff:
Satheesh Thomas
Kogus v. Five Prime Therapeutics, Inc. et al
as 1:2021cv00502
Defendant:
Peder K. Jensen, Thomas Civik, Carol Schafer and others
Plaintiff:
Esther Kogus
CICCOTELLI v. FIVE PRIME THERAPEUTICS, INC. et al
as 2:2021cv01512
Defendant:
FRANKLIN ACQUISITION SUB, INC., GARRY NICHOLSON, PEDER K JENSEN and others
Plaintiff:
ALEX CICCOTELLI
Cause Of Action: 12 U.S.C. § 22
Mills v. Five Prime Therapeutics, Inc. et al
as 1:2021cv02718
Defendant:
Peder K. Jensen, Thomas Civik, Carol Schafer and others
Plaintiff:
Timothy Mills
Wheeler v. Five Prime Therapeutics, Inc. et al
as 4:2021cv02097
Defendant:
Peder K. Jensen, Thomas Civik, Carol Schafer and others
Plaintiff:
Jacob Wheeler
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
